Literature DB >> 16804738

Effects of rheumatoid factor isotypes on disease activity and severity in patients with rheumatoid arthritis: a comparative study.

Aşkin Ateş1, Gülay Kinikli, Murat Turgay, Gülay Akay, Güner Tokgöz.   

Abstract

The value of rheumatoid factor (RF) isotypes for assessing rheumatoid arthritis (RA) remains debatable. In this study, we have examined the relationships between RF isotypes and disease activity and severity in RA patients. Sixty-two patients with RA, 48 women and 14 men, were studied. RF was measured by nephelometry (RF-N) and IgG-, IgA-, and IgM-RF isotypes were measured using enzyme-linked immunosorbent assay. Serum C-reactive protein and erythrocyte sedimentation rate were also determined. The patients were classified according to disease activity, joint damage, functional status, and presence of pulmonary involvement, rheumatoid nodule, and secondary Sjögren's syndrome. Although the patients with active disease had significantly higher IgA-RF and IgM-RF levels compared to inactive patients, IgA-RF and IgM-RF were not found to be independently associated with disease activity in multivariate analysis. In patients with severe joint damage, IgA-RF and RF-N were significantly higher than those of the other patients. Multiple regression analysis showed that IgA-RF was the unique variable independently associated to severe joint damage. The patients with class III and IV functional index had significantly higher IgM-RF, IgA-RF, and RF-N levels compared to the patients with class I and II functional index; however, RFs were not significantly associated with functional status in multivariate analysis. IgA-RF and IgM-RF were significantly associated with pulmonary involvement and rheumatoid nodule, respectively. No significant associations were found between RF isotypes and secondary Sjögren's syndrome. Our results suggest that the clinical usefulness of IgA and IgM isotypes is better than RF-N. Elevated IgA-RF may be a marker of erosive disease. The usefulness of RF isotypes for monitoring disease activity or functional status appears to be limited.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16804738     DOI: 10.1007/s10067-006-0343-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  29 in total

1.  Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films.

Authors:  A Larsen; K Dale; M Eek
Journal:  Acta Radiol Diagn (Stockh)       Date:  1977-07

2.  Discrepancy in the expression of autoantibodies in healthy aged individuals.

Authors:  F Silvestris; W Anderson; J S Goodwin; R C Williams
Journal:  Clin Immunol Immunopathol       Date:  1985-05

3.  Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis.

Authors:  S Bas; S Genevay; O Meyer; C Gabay
Journal:  Rheumatology (Oxford)       Date:  2003-05       Impact factor: 7.580

4.  Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth" strategy.

Authors:  T Möttönen; L Paimela; M Leirisalo-Repo; H Kautiainen; J Ilonen; P Hannonen
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

5.  Isotype-specific measurement of rheumatoid factor with reference to clinical features of rheumatoid arthritis.

Authors:  A Tarkowski; L A Nilsson
Journal:  J Clin Lab Immunol       Date:  1983-11

6.  IgM rheumatoid factor (RF), IgA RF, IgE RF, and IgG RF detected by ELISA in rheumatoid arthritis.

Authors:  M Gioud-Paquet; M Auvinet; T Raffin; P Girard; M Bouvier; E Lejeune; J C Monier
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

7.  Comparison of five assays for immune complexes in the rheumatic diseases. An assessment of their validity for rheumatoid arthritis.

Authors:  J S McDougal; M Hubbard; F C McDuffie; P L Strobel; S J Smith; N Bass; J A Goldman; S Hartman; G Myerson; S Miller; R Morales; C H Wilson
Journal:  Arthritis Rheum       Date:  1982-10

8.  Clinical significance of rheumatoid factor isotypes in seropositive arthritis.

Authors:  T Jónsson; H Valdimarsson
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

9.  Prospective study of early rheumatoid arthritis. II. Association of rheumatoid factor isotypes with fluctuations in disease activity.

Authors:  R H Withrington; I Teitsson; H Valdimarsson; M H Seifert
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

10.  Rheumatoid factors in rheumatoid arthritis and vasculitis.

Authors:  M L Westedt; P Herbrink; J L Molenaar; E de Vries; P Verlaan; T Stijnen; A Cats; J Lindeman
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

View more
  10 in total

Review 1.  2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.

Authors:  Jasvinder A Singh; Daniel E Furst; Aseem Bharat; Jeffrey R Curtis; Arthur F Kavanaugh; Joel M Kremer; Larry W Moreland; James O'Dell; Kevin L Winthrop; Timothy Beukelman; S Louis Bridges; W Winn Chatham; Harold E Paulus; Maria Suarez-Almazor; Claire Bombardier; Maxime Dougados; Dinesh Khanna; Charles M King; Amye L Leong; Eric L Matteson; John T Schousboe; Eileen Moynihan; Karen S Kolba; Archana Jain; Elizabeth R Volkmann; Harsh Agrawal; Sangmee Bae; Amy S Mudano; Nivedita M Patkar; Kenneth G Saag
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-05       Impact factor: 4.794

2.  Association of PTPN22 1858C→T polymorphism, HLA-DRB1 shared epitope and autoantibodies with rheumatoid arthritis.

Authors:  Hala M Raslan; Hanaa R Attia; Iman Salama; Mona Hamed Ibrahim; Eman Mahmoud Hassan; Mohamed S El Hussieny; Manal M El Menyawi; Khalda S Amr
Journal:  Rheumatol Int       Date:  2016-06-20       Impact factor: 2.631

Review 3.  Autoantibodies and other serological markers in rheumatoid arthritis: predictors of disease activity?

Authors:  Licia Maria Henrique da Mota; Leopoldo Luiz dos Santos Neto; Jozélio Freire de Carvalho
Journal:  Clin Rheumatol       Date:  2009-07-14       Impact factor: 2.980

4.  Relation of rheumatoid factor and anti-cyclic citrullinated peptide antibody with disease activity in rheumatoid arthritis: cross-sectional study.

Authors:  Jung-Yoon Choe; Jisuk Bae; Hwajeong Lee; Sang-Cheol Bae; Seong-Kyu Kim
Journal:  Rheumatol Int       Date:  2013-04-04       Impact factor: 2.631

Review 5.  Rheumatoid factors and anticyclic citrullinated peptide antibodies in pediatric rheumatology.

Authors:  Reema H Syed; Brooke E Gilliam; Terry L Moore
Journal:  Curr Rheumatol Rep       Date:  2008-04       Impact factor: 4.592

6.  Cigarette smoking, disease severity and autoantibody expression in African Americans with recent-onset rheumatoid arthritis.

Authors:  T R Mikuls; L B Hughes; A O Westfall; V M Holers; L Parrish; D van der Heijde; M van Everdingen; G S Alarcón; D L Conn; B Jonas; L F Callahan; E A Smith; G Gilkeson; G Howard; L W Moreland; S L Bridges
Journal:  Ann Rheum Dis       Date:  2008-01-15       Impact factor: 19.103

Review 7.  Laboratory evaluation in rheumatic diseases.

Authors:  Murat Birtane; Selçuk Yavuz; Nurettin Taştekin
Journal:  World J Methodol       Date:  2017-03-26

Review 8.  The Expression of Non-Coding RNAs and Their Target Molecules in Rheumatoid Arthritis: A Molecular Basis for Rheumatoid Pathogenesis and Its Potential Clinical Applications.

Authors:  Chang-Youh Tsai; Song-Chou Hsieh; Chih-Wei Liu; Cheng-Hsun Lu; Hsien-Tzung Liao; Ming-Han Chen; Ko-Jen Li; Cheng-Han Wu; Cheih-Yu Shen; Yu-Min Kuo; Chia-Li Yu
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

9.  Rheumatoid factor as predictor of response to treatment with anti-TNF alpha drugs in patients with rheumatoid arthritis: Results of a cohort study.

Authors:  Pedro Santos-Moreno; Guillermo Sánchez; Carlos Castro
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

10.  Increased Serum Interleukin-2 Levels Are Associated with Abnormal Peripheral Blood Natural Killer Cell Levels in Patients with Active Rheumatoid Arthritis.

Authors:  Baochen Li; Qiaoling Guo; Yanyan Wang; Rui Su; Chong Gao; Jinfang Zhao; Xiaofeng Li; Caihong Wang
Journal:  Mediators Inflamm       Date:  2020-09-15       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.